Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|May 22, 2023
A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.Cell Death Discovery|November 17, 2024
Therapeutic advances in the targeting of ROR1 in hematological cancersAdrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, et al.Frontiers in Oncology|November 16, 2020
A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AMLAlexander J Ambinder, Kelly Norsworthy, Daniela Hernandez, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.Cell Death & Disease|July 17, 2025
Humanized mouse models in MDSRaluca Munteanu, Diana Gulei, Cristian Silviu Moldovan, et al.Blood|July 1, 2020
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activityMeisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, et al.Proceedings of the National Academy of Sciences of the United States of America|May 22, 2012
Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cellsEri Taniguchi Ishikawa, Daniel Gonzalez-Nieto, Gabriel Ghiaur, et al.Blood|April 23, 2016
All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivoHayley S Ma, Sarah M Greenblatt, Courtney M Shirley, et al.Blood Reviews|June 8, 2023
Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myelomaDavid Kegyes, Diana Gulei, Rares Drula, et al.Blood Advances|February 28, 2025
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemiaFarhad Ravandi, Sravanti Rangaraju, Hagop Kantarjian, et al.Pageof 10